Rephonic
Artwork for Lung Cancer Considered

Lung Cancer Considered

IASLC
Lung Cancer
Immunotherapy
Non-Small Cell Lung Cancer
Thoracic Oncology
Targeted Therapy
Clinical Trials
Osimertinib
Biomarker Testing
Molecular Testing
Chemotherapy
Egfr
Small Cell Lung Cancer
Liquid Biopsy
EGFR Mutation
IASLC World Conference On Lung Cancer
IASLC
Neoadjuvant Therapy
ASCO 2024
Chemoimmunotherapy
Egfr-Mutant Non-Small Cell Lung Cancer

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 co... more

PublishesWeeklyEpisodes399Founded7 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Lung Cancer Considered

Latest Episodes

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilience. Drawing from their personal and professional ex... more

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The discussion reviews advances in ALK+ non-small cel... more

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined by Dr. Nicolas Girard and Dr. Erica Pietroluongo ... more

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephen Liu, Dr. Alexander Drilon, and Dr. Rosario Charo... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Rx
Lung Cancer RxOncology News Central
Plenary Session
Plenary SessionVinay Prasad, MD MPH
JTO Insights
JTO InsightsJTO Insights

Recent Guests

Nicolas Girard
Professor of Respiratory Medicine, Versailles; expert in thymic tumors
Institut Curie / Versailles University
Episode: Treating Advanced Thymic Cancers
Erica Pietroluongo
Medical Oncologist, thymic tumors specialist
University of Naples / University of Chicago (Visiting Scholar)
Episode: Treating Advanced Thymic Cancers
Alex Drilon
Lead investigator of the EROS1 study, Chief of the Early Drug Development Service and the Carol Bassick Lowenstein Chair at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: FDA Approval: Zidesamtinib and ROS1 NSCLC
Rosario Garcia Campelo
Head of Medical Oncology and the Thoracic Tumor Unit Chair in the University Hospital, and Head of the Oncology Research Group of the Biomedical Research Institute, Caruña, Spain
University Hospital; Biomedical Research Institute, Caruña (A Coruña), Spain
Episode: FDA Approval: Zidesamtinib and ROS1 NSCLC
Vincent Lam
Associate Professor of Oncology, Johns Hopkins University; ARCHER trial lead
Johns Hopkins University
Episode: Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer
Carmen Mecca
Postdoctoral researcher, lab of Dr. Roberto Chiarle; ALK TCR/engineered T cells research
Boston Children's Hospital / Harvard Medical School
Episode: Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer
Balazs Halmos
Professor of Medicine and leading thoracic oncologist
Montefiore Einstein Medical Center (Bronx, New York)
Episode: Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered
Min Yoon Ahn
Conference co-chair, Professor, Hanyang University Medical Center, Department of Hematology and Oncology
Hanyang University Medical Center
Episode: Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview
Jiraporn Setakornnukul
Conference co-chair, Radiation Oncologist
Siriraj Hospital Mahidol University
Episode: Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Hosts

Narjust Florez
Host of Lung Cancer Considered; clinical researcher with affiliations at Harvard Medical School and IASLC; focuses on thoracic oncology and translational lung cancer biology.
Dr. Stephen Liu
Co-Host; physician-scientist specializing in hematology/oncology with leadership roles in thoracic oncology.

Reviews

4.6 out of 5 stars from 46 ratings
  • Episode on Immunotherapy

    Really enjoyed the conversation between these oncologist. They seem to be great doctors who really care for their patients are working for the best solutions they know of.

    It was also interesting to see their blind spots. The great thing about immunotherapy is slowly opening the door between integrative oncology and traditional oncology. These guys don’t get into it but they are asking the right questions.

    1) What can be combined with immunotherapy?

    2) What can be done to prevent side effec... more

    Apple Podcasts
    5
    TBobo
    United States4 years ago
  • Fantastic for doctors, nurses, patients

    Great conversations on all things lung cancer.

    Apple Podcasts
    5
    DrFLC
    United States5 years ago
  • :)

    great info!

    Apple Podcasts
    5
    yeoohaz
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Audience notes the mix of clinical data interpretation and real-world access issues.
Many appreciate practical takeaways and emphasis on biomarker-driven care.
Listeners praise expert clinical insight and balanced discussion of evolving therapies.
Guests are seen as credible, knowledgeable, and helpful for planning treatment and trials.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#137
Hong Kong/Science
Apple Podcasts
#246
Philippines/Science

Talking Points

Recent interactions between the hosts and their guests.

FDA Approval: Zidesamtinib and ROS1 NSCLC
Q: What is the current treatment approach for ROS1 fusions in the US and how does Zidesamtinib fit into it?
ROS1-targeted therapy remains foundational after progression on initial TKIs, with Zidesamtinib offering strong activity in both single- and multi-TKI-exposed patients, plus notable CNS activity; the drug may become a standard option post prior ROS1 inhibition and potentially move earlier in the treatment sequence as data mature.
Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered
Q: Balazs, how was it to be in that moment of history when you were involved in understanding the resistant mechanisms to a mutation that at that time we thought we understood?
It was magical and revealing; the field showed that even well-characterized mutations could develop resistance, which validated the need to study resistance mechanisms and pursue new inhibitors and strategies.
IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research
Q: What is the role of activity and rehabilitation in lung cancer care?
Morten describes how activity helps maintain function and independence, using analogies of rehearsing to illustrate how patients can gradually improve capability and quality of life.
IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research
Q: How can patients' nutritional needs and muscle mass be better managed during treatment?
The discussion emphasizes addressing malnutrition not just as weight loss but muscle loss, using medical nutrition therapy, psychosocial support, and a multidisciplinary team to maintain function and quality of life.
IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research
Q: So, Nicole, from your perspective, why was it important to have a dedicated committee to nursing and allied professionals within IASLC?
Nicole explains that nurses and allied health professionals play a crucial, day-to-day role across the cancer journey, and a formal mechanism helps elevate their expertise and ensure it informs the broader organization and patient care.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Considered

What is Lung Cancer Considered about and what kind of topics does it cover?

Listener-friendly overview: This show centers on thoracic oncology, with in-depth discussions of targeted therapies, immunotherapies, molecular testing, and real-world sequencing and testing challenges. Guests range from leading clinicians and researchers to patient advocates, delivering practical insights on trial data, biomarker-driven care, and how global practices influence care access. Episodes often explore testing gaps, perioperative decisions, and the evolving landscape of EGFR, ALK, ROS1, KRAS, and RET–driven NSCLC, plus reflections on career development and multidisciplinary collaboration. A standout angle is translating complex trial results into actionable clinical guidance while highlighting global disparities and pathways to i... more

Where can I find podcast stats for Lung Cancer Considered?

Rephonic provides a wide range of podcast stats for Lung Cancer Considered. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Considered and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Considered get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Considered, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Considered?

Rephonic provides comprehensive predictive audience data for Lung Cancer Considered, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Considered have?

To see how many followers or subscribers Lung Cancer Considered has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Considered?

These podcasts share a similar audience with Lung Cancer Considered:

1. Lung Cancer Update
2. Two Onc Docs
3. Lung Cancer Rx
4. Plenary Session
5. JTO Insights

How many episodes of Lung Cancer Considered are there?

Lung Cancer Considered launched 7 years ago and published 399 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Considered?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Considered?

Rephonic pulls ratings and reviews for Lung Cancer Considered from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Considered?

Rephonic provides full transcripts for episodes of Lung Cancer Considered. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Considered?

Recent guests on Lung Cancer Considered include:

1. Nicolas Girard
2. Erica Pietroluongo
3. Alex Drilon
4. Rosario Garcia Campelo
5. Vincent Lam
6. Carmen Mecca
7. Balazs Halmos
8. Min Yoon Ahn

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days